Announcements Trials

Browse Landscape

Phase

Status

Completed 5 Recruiting 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 10 Hodgkin Disease 5 Lymphoma 3 Sarcoma 2 Thyroid Neoplasms 1 Recurrence 1 Neoplasm Metastasis 1 Leiomyosarcoma 1 Carcinoma, Medullary 1

Interventions

pazopanib 2 Trabectedin 2 Doxorubicin 2 sapanisertib 1 rucaparib 1 pembrolizumab 1 itacitinib 1 baricitinib 1 avelumab 1 Vorinostat 1 TTI-621 1 PTC596 1 Letrozole 1 Ifosfamide 1 INCB039110 1 Docetaxel 1 Dacarbazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Leiomyosarcoma × Dacarbazine × Clear all

NCT05269355 2025-06-13

SUNRISELMS

PTC Therapeutics

Phase 2/3 Terminated

359 enrolled 15 charts

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡